278 related articles for article (PubMed ID: 26915359)
1. Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.
Okuma Y; Hosomi Y; Miyamoto S; Shibuya M; Okamura T; Hishima T
BMC Cancer; 2016 Feb; 16():156. PubMed ID: 26915359
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma.
Okuma Y; Goto Y; Ohyanagi F; Sunami K; Nakahara Y; Kitazono S; Kudo K; Tambo Y; Kanda S; Yanagitani N; Horiike A; Horinouchi H; Fujiwara Y; Nokihara H; Yamamoto N; Nishio M; Ohe Y; Hosomi Y
Cancer Med; 2020 Oct; 9(20):7418-7427. PubMed ID: 32813912
[TBL] [Abstract][Full Text] [Related]
3. Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer.
Kaira K; Naruse I; Imai H; Sunaga N; Hisada T; Motegi M; Asao T; Yamada M
Chemotherapy; 2014; 60(5-6):356-9. PubMed ID: 26389778
[TBL] [Abstract][Full Text] [Related]
4. Successful S-1 monotherapy for chemorefractory thymic carcinoma.
Koizumi T; Agatsuma T; Komatsu Y; Kubo K
Anticancer Res; 2011 Jan; 31(1):299-301. PubMed ID: 21273614
[TBL] [Abstract][Full Text] [Related]
5. S-1 treatment for chemorefractory thymic carcinoma.
Ono A; Naito T; Yamamoto N
J Thorac Oncol; 2008 Sep; 3(9):1076. PubMed ID: 18758317
[No Abstract] [Full Text] [Related]
6. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Thomas A; Rajan A; Berman A; Tomita Y; Brzezniak C; Lee MJ; Lee S; Ling A; Spittler AJ; Carter CA; Guha U; Wang Y; Szabo E; Meltzer P; Steinberg SM; Trepel JB; Loehrer PJ; Giaccone G
Lancet Oncol; 2015 Feb; 16(2):177-86. PubMed ID: 25592632
[TBL] [Abstract][Full Text] [Related]
7. S-1 is an active anticancer agent for advanced thymic carcinoma.
Okuma Y; Shimokawa T; Takagi Y; Hosomi Y; Iguchi M; Okamura T; Shibuya M
Lung Cancer; 2010 Dec; 70(3):357-63. PubMed ID: 20951466
[TBL] [Abstract][Full Text] [Related]
8. Results of S-1-based chemotherapy for platinum (and antrathycline)-refractory advanced thymic carcinoma.
Hirai F; Seto T; Inamasu E; Toyokawa G; Yoshida T; Nosaki K; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Anticancer Res; 2014 Oct; 34(10):5743-7. PubMed ID: 25275083
[TBL] [Abstract][Full Text] [Related]
9. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
10. Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.
Koda K; Miyauchi H; Kosugi C; Kaiho T; Takiguchi N; Kobayashi S; Maruyama T; Matsubara H;
Anticancer Res; 2016 Oct; 36(10):5325-5331. PubMed ID: 27798895
[TBL] [Abstract][Full Text] [Related]
11. Multicenter phase II trial of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.
Naito S; Eto M; Shinohara N; Tomita Y; Fujisawa M; Namiki M; Nishikido M; Usami M; Tsukamoto T; Akaza H
J Clin Oncol; 2010 Dec; 28(34):5022-9. PubMed ID: 20975067
[TBL] [Abstract][Full Text] [Related]
12. Final results of a phase II study of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.
Naito S; Tatsugami K; Shinohara N; Tomita Y; Mizokami A; Fujisawa M; Hashine K; Nishikido M; Nakagawa M; Tsukamoto T; Akaza H
Jpn J Clin Oncol; 2014 Feb; 44(2):122-6. PubMed ID: 24298041
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.
Asao T; Fujiwara Y; Sunami K; Kitahara S; Goto Y; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Ichikawa H; Kohno T; Tsuta K; Watanabe S; Takahashi K; Ohe Y
Lung Cancer; 2016 Mar; 93():77-81. PubMed ID: 26898618
[TBL] [Abstract][Full Text] [Related]
14. Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.
Liang Y; Padda SK; Riess JW; West RB; Neal JW; Wakelee HA
Lung Cancer; 2015 Jan; 87(1):34-8. PubMed ID: 25443273
[TBL] [Abstract][Full Text] [Related]
15. [A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period].
Takata M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Tamura M; Takemura H; Ikeda H
Gan To Kagaku Ryoho; 2017 Mar; 44(3):239-242. PubMed ID: 28292994
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
Harada K; Kawashima Y; Yoshida H; Sato M
Oncol Rep; 2006 Jun; 15(6):1417-23. PubMed ID: 16685374
[TBL] [Abstract][Full Text] [Related]
17. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: a prospective multi-institutional study in Japan.
Eguchi K; Oyama T; Tajima A; Abiko T; Sawafuji M; Horio H; Hashizume T; Matsutani N; Kato R; Nakayama M; Kawamura M; Kobayashi K
Lung Cancer; 2015 Jan; 87(1):53-8. PubMed ID: 25468199
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.
Peng PJ; Cheng H; Ou XQ; Zeng LJ; Wu X; Liu YM; Lin Z; Tang YN; Wang SY; Zhang HY; Chen ZB
Drug Des Devel Ther; 2014; 8():1083-7. PubMed ID: 25152614
[TBL] [Abstract][Full Text] [Related]
20. Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer.
Kim JY; Shin E; Kim JW; Lee HS; Lee DW; Kim SH; Lee JO; Kim YJ; Kim JH; Bang SM; Ahn SH; Park DJ; Lee JS; Lee JS; Kim HH; Lee KW
PLoS One; 2015; 10(3):e0120324. PubMed ID: 25793299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
